Highlights

[IQZAN] YoY Quarter Result on 2020-06-30 [#1]

Stock [IQZAN]: IQZAN HOLDING BERHAD
Announcement Date 28-Aug-2020
Admission Sponsor -
Sponsor -
Financial Year 31-Mar-2021
Quarter 30-Jun-2020  [#1]
Profit Trend QoQ -     -89.58%    YoY -     -99.83%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
Revenue 2,927 1,168 3,648 2,836 26,038 35,416 31,799 -36.49%
  YoY % 150.60% -67.98% 28.63% -89.11% -26.48% 11.37% -
  Horiz. % 9.20% 3.67% 11.47% 8.92% 81.88% 111.37% 100.00%
PBT 50 58 -803 7,390 -2,031 -1,855 -2,413 -
  YoY % -13.79% 107.22% -110.87% 463.86% -9.49% 23.12% -
  Horiz. % -2.07% -2.40% 33.28% -306.26% 84.17% 76.88% 100.00%
Tax -15 4 721 240 -17 -560 -227 -40.37%
  YoY % -475.00% -99.45% 200.42% 1,511.76% 96.96% -146.70% -
  Horiz. % 6.61% -1.76% -317.62% -105.73% 7.49% 246.70% 100.00%
NP 35 62 -82 7,630 -2,048 -2,415 -2,640 -
  YoY % -43.55% 175.61% -101.07% 472.56% 15.20% 8.52% -
  Horiz. % -1.33% -2.35% 3.11% -289.02% 77.58% 91.48% 100.00%
NP to SH 20 62 -175 11,862 -2,112 -2,585 -2,620 -
  YoY % -67.74% 135.43% -101.48% 661.65% 18.30% 1.34% -
  Horiz. % -0.76% -2.37% 6.68% -452.75% 80.61% 98.66% 100.00%
Tax Rate 30.00 % -6.90 % - % -3.25 % - % - % - % -
  YoY % 534.78% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % -923.08% 212.31% 0.00% 100.00% - - -
Total Cost 2,892 1,106 3,730 -4,794 28,086 37,831 34,439 -37.59%
  YoY % 161.48% -70.35% 177.81% -117.07% -25.76% 9.85% -
  Horiz. % 8.40% 3.21% 10.83% -13.92% 81.55% 109.85% 100.00%
Net Worth 33,277 46,219 33,933 46,219 45,737 73,286 75,159 -14.36%
  YoY % -28.00% 36.21% -26.58% 1.05% -37.59% -2.49% -
  Horiz. % 44.28% 61.49% 45.15% 61.49% 60.85% 97.51% 100.00%
Dividend
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
Net Worth 33,277 46,219 33,933 46,219 45,737 73,286 75,159 -14.36%
  YoY % -28.00% 36.21% -26.58% 1.05% -37.59% -2.49% -
  Horiz. % 44.28% 61.49% 45.15% 61.49% 60.85% 97.51% 100.00%
NOSH 184,876 184,876 141,389 184,876 134,522 133,247 122,429 8.16%
  YoY % 0.00% 30.76% -23.52% 37.43% 0.96% 8.84% -
  Horiz. % 151.01% 151.01% 115.49% 151.01% 109.88% 108.84% 100.00%
Ratio Analysis
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
NP Margin 1.20 % 5.31 % -2.25 % 269.04 % -7.87 % -6.82 % -8.30 % -
  YoY % -77.40% 336.00% -100.84% 3,518.55% -15.40% 17.83% -
  Horiz. % -14.46% -63.98% 27.11% -3,241.45% 94.82% 82.17% 100.00%
ROE 0.06 % 0.13 % -0.52 % 25.66 % -4.62 % -3.53 % -3.49 % -
  YoY % -53.85% 125.00% -102.03% 655.41% -30.88% -1.15% -
  Horiz. % -1.72% -3.72% 14.90% -735.24% 132.38% 101.15% 100.00%
Per Share
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
RPS 1.58 0.63 2.58 1.53 19.36 26.58 25.97 -41.30%
  YoY % 150.79% -75.58% 68.63% -92.10% -27.16% 2.35% -
  Horiz. % 6.08% 2.43% 9.93% 5.89% 74.55% 102.35% 100.00%
EPS 0.01 0.03 -0.12 6.42 -1.57 -1.94 -2.14 -
  YoY % -66.67% 125.00% -101.87% 508.92% 19.07% 9.35% -
  Horiz. % -0.47% -1.40% 5.61% -300.00% 73.36% 90.65% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1800 0.2500 0.2400 0.2500 0.3400 0.5500 0.6139 -20.82%
  YoY % -28.00% 4.17% -4.00% -26.47% -38.18% -10.41% -
  Horiz. % 29.32% 40.72% 39.09% 40.72% 55.38% 89.59% 100.00%
Adjusted Per Share Value based on latest NOSH - 184,866
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
RPS 1.58 0.63 1.97 1.53 14.08 19.16 17.20 -36.51%
  YoY % 150.79% -68.02% 28.76% -89.13% -26.51% 11.40% -
  Horiz. % 9.19% 3.66% 11.45% 8.90% 81.86% 111.40% 100.00%
EPS 0.01 0.03 -0.09 6.42 -1.14 -1.40 -1.42 -
  YoY % -66.67% 133.33% -101.40% 663.16% 18.57% 1.41% -
  Horiz. % -0.70% -2.11% 6.34% -452.11% 80.28% 98.59% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1800 0.2500 0.1836 0.2500 0.2474 0.3964 0.4066 -14.36%
  YoY % -28.00% 36.17% -26.56% 1.05% -37.59% -2.51% -
  Horiz. % 44.27% 61.49% 45.15% 61.49% 60.85% 97.49% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
Date 30/06/20 30/09/19 28/09/18 28/06/19 31/03/17 31/03/16 31/03/15 -
Price 0.0700 0.1000 0.1350 0.0750 0.2250 0.2450 0.3650 -
P/RPS 4.42 15.83 5.23 4.89 1.16 0.92 1.41 24.29%
  YoY % -72.08% 202.68% 6.95% 321.55% 26.09% -34.75% -
  Horiz. % 313.48% 1,122.70% 370.92% 346.81% 82.27% 65.25% 100.00%
P/EPS 647.07 298.19 -109.07 1.17 -14.33 -12.63 -17.06 -
  YoY % 117.00% 373.39% -9,422.22% 108.16% -13.46% 25.97% -
  Horiz. % -3,792.91% -1,747.89% 639.33% -6.86% 84.00% 74.03% 100.00%
EY 0.15 0.34 -0.92 85.55 -6.98 -7.92 -5.86 -
  YoY % -55.88% 136.96% -101.08% 1,325.64% 11.87% -35.15% -
  Horiz. % -2.56% -5.80% 15.70% -1,459.90% 119.11% 135.15% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.39 0.40 0.56 0.30 0.66 0.45 0.59 -7.58%
  YoY % -2.50% -28.57% 86.67% -54.55% 46.67% -23.73% -
  Horiz. % 66.10% 67.80% 94.92% 50.85% 111.86% 76.27% 100.00%
Price Multiplier on Announcement Date
30/06/20 30/09/19 30/09/18 30/06/19 31/03/17 31/03/16 31/03/15 CAGR
Date 28/08/20 29/11/19 28/11/18 30/08/19 01/06/17 27/05/16 29/05/15 -
Price 0.1800 0.0950 0.1300 0.1100 0.1900 0.2600 0.3400 -
P/RPS 11.37 15.04 5.04 7.17 0.98 0.98 1.31 50.87%
  YoY % -24.40% 198.41% -29.71% 631.63% 0.00% -25.19% -
  Horiz. % 867.94% 1,148.09% 384.73% 547.33% 74.81% 74.81% 100.00%
P/EPS 1,663.88 283.28 -105.03 1.71 -12.10 -13.40 -15.89 -
  YoY % 487.36% 369.71% -6,242.10% 114.13% 9.70% 15.67% -
  Horiz. % -10,471.24% -1,782.76% 660.98% -10.76% 76.15% 84.33% 100.00%
EY 0.06 0.35 -0.95 58.33 -8.26 -7.46 -6.29 -
  YoY % -82.86% 136.84% -101.63% 806.17% -10.72% -18.60% -
  Horiz. % -0.95% -5.56% 15.10% -927.34% 131.32% 118.60% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.00 0.38 0.54 0.44 0.56 0.47 0.55 12.05%
  YoY % 163.16% -29.63% 22.73% -21.43% 19.15% -14.55% -
  Horiz. % 181.82% 69.09% 98.18% 80.00% 101.82% 85.45% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

2170 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SCOMNET 2.300.00 
 KOTRA 3.180.00 
 UCREST 0.140.00 
 GENM-C73 0.0050.00 
 PUC 0.240.00 
 WILLOW 0.4250.00 
 EAH-WE 0.0150.00 
 IRIS 0.260.00 
 TOPGLOV-C79 0.4150.00 
 BTECH 0.4550.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
3. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS